Advance Vixeid Partners

What is Advance Vixeid Partners?

Advance Vixeid Partners, also known as Blue Heron Capital, is an early-stage growth equity firm that focuses on funding innovative ideas in the healthcare and enterprise technology sectors. Through a strategic blend of financial capital and the human capital of their Operational Alignment Collaborative, the firm aims to build businesses that have a significant impact. They define their edge with their approach to help companies align their teams to work towards a common direction.

Specializing in equity investment, Blue Heron Capital's investment expertise extends to Expansion, Management Buyouts/Leveraged Buyouts (MBO/LBO), Acquisition, and Secondary Purchase transactions. Founded on the principles of partnership and mutual growth, Blue Heron Capital believes that the entrepreneurial journey is one of close collaboration, built upon a foundation of trust, care, and mutual understanding.

They emphasize that a successful investment goes beyond the figures on paper, relying on financial expertise paired with real-world experience to achieve operational success. The firm also places a strong emphasis on value alignment and seeks to establish partnerships based on trust and a shared vision.

Described by its co-founder, Tom Benedetti, Blue Heron Capital prides itself on investing boldly in businesses and teams that are striving to enact bold and positive change, while also maintaining a passion for their work and enjoying the entrepreneurial journey. The firm's headquarter is located at 1519 Summit Avenue, Suite 200, Richmond, Virginia, 23230, United States.